Tumor-derived exosomes: A message delivery system for tumor progression

Communicative and Integrative Biology

Volumn 7, Issue 2, 2014, Pages

  Atay, Safinur ^a   Godwin, Andrew ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

Exosomes; Feedback loop; GIST; Invasion; Tumor micro environment

Indexed keywords

EID: 84901315268     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.28231     Document Type: Article

References (91)

1. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-79; PMID:12154376
2. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3:Unit 3 22.
3. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 1997; 8:2631-45; PMID:9398681; http://dx.doi.org/10.1091/mbc.8.12.2631
4. Caramori G, Fabbri M, Paioli D, Falcone F, Severino C, Felisatti G, Arar O, Adcock IM, Fan Chung K, Barnes PJ, et al. Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. Monaldi Arch Chest Dis 2005; 63:84-7; PMID:16128222
5. Théry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Molecular characterization of dendritic cellderived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999; 147:599-610; PMID:10545503; http://dx.doi.org/10.1083/jcb.147.3.599
6. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987; 262:9412-20; MID:3597417
7. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001; 121:337-49; PMID:11487543; http://dx.doi.org/10.1053/gast.2001.26263
8. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183:1161-72; PMID:8642258; http://dx.doi.org/10.1084/jem.183.3.1161
9. Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol 2011; 65:65-77; PMID:20560914; http://dx.doi.org/10.1111/j.1600-897.2010.00880.x
10. Atay S, Gercel-Taylor C, Taylor DD. Human trophoblast-derived exosomal fibronectin induces pro-inf lammatory IL-1ß production by macrophages. Am J Reprod Immunol 2011; 66:259-69; PMID:21410811; http://dx.doi.org/10.1111/j.1600-0897.2011.00995.x
11. Fauré J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, Grange J, Schoehn G, Goldberg Y, Boyer V, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006; 31:642-8; PMID:16446100; http://dx.doi.org/10.1016/j.mcn.2005.12.003
12. Taylor DD, Taylor CG, Jiang CG, Black PH. Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer 1988; 41:629-35; PMID:3356493; http://dx.doi.org/10.1002/ijc.2910410425
13. Taylor DD, Lyons KS, Gerçel-Taylor C. Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol 2002; 84:443-8; PMID:11855885; http://dx.doi.org/10.1006/gyno.2001.6551
14. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE. Proteomic analysis of melanoma-derived exosomes by twodimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004; 4:4019-31; PMID:15478216; http://dx.doi.org/10.1002/pmic.200400876
15. Admyre C, Grunewald J, Thyberg J, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 2003; 22:578-83; PMID:14582906; http://dx.doi.org/10.1183/09031936.03.00041703
16. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17:879-87; PMID:15908444; http://dx.doi. org/10.1093/intimm/dxh267
17. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002; 360:295-305; PMID:12147373; http://dx.doi.org/10.1016/S0140-6736(02)09552-1
18. Navabi H, Croston D, Hobot J, Clayton A, Zitvogel L, Jasani B, Bailey-Wood R, Wilson K, Tabi Z, Mason MD, et al. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis 2005; 35:149-52; PMID:16061407; http://dx.doi.org/10.1016/j.bcmd.2005.06.008
19. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004; 101:13368-73; PMID:15326289; http://dx.doi.org/10.1073/pnas.0403453101
20. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancyassociated exosomes and their modulation of T cell signaling. J Immunol 2006; 176:1534-42; PMID:16424182
21. Admyre C, Johansson SM, Qazi KR, Filén JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007; 179:1969-78; PMID:17641064
22. Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 2008; 31:1059-62; PMID:18520029; http://dx.doi.org/10.1248/bpb.31.1059
23. Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 2004; 31:114-21; PMID:14975938; http://dx.doi.org/10.1165/rcmb.2003-0238OC
24. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 2009; 23:1541-57; PMID:19109410; http://dx.doi.org/10.1096/fj.08-122184
25. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics 2008; 8:4083-99; PMID:18780348; http://dx.doi.org/10.1002/pmic.200800109
26. Xue H, Lü B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010; 9:545-55; PMID:19924834; http://dx.doi.org/10.1021/pr9008817 www.landesbioscience.com Communicative & Integrative Biology e28231-5
27. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, Hivroz C. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 2002; 168:3235-41; PMID:11907077
28. Subra C, Laulagnier K, Perret B, Record M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 2007; 89:205-12; PMID:17157973; http://dx.doi.org/10.1016/j.biochi.2006.10.014
29. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. Cellular internalization of exosomes occurs through phagocytosis. Traffic 2010; 11:675-87; PMID:20136776; http://dx.doi.org/10.1111/j.1600-0854.2010.01041.x
30. Olver C, Vidal M. Proteomic analysis of secreted exosomes. Subcell Biochem 2007; 43:99-131; PMID:17953393; http://dx.doi.org/10.1007/978-1-4020-5943-8_7
31. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009; 6:267-83; PMID:19489699; http://dx.doi.org/10.1586/epr.09.17
32. Clayton A, Mason MD. Exosomes in tumour immunity. Curr Oncol 2009; 16:46-9; PMID:19526085; http://dx.doi.org/10.3747/co.v16i3.367
33. Atay S, Gercel-Taylor C, Kesimer M, Taylor DD. Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp Cell Res 2011; 317:1192-202; PMID:21276792; http://dx.doi.org/10.1016/j.yexcr.2011.01.014
34. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004; 164:1807-15; PMID:15111327; http://dx.doi.org/10.1016/S0002-9440(10)63739-X
35. Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, Czupryna A, Szczepanik A, Zembala M. Circulating tumourderived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010; 59:841-50; PMID:20043223; http://dx.doi.org/10.1007/s00262-009-0808-2
36. Staubach S, Razawi H, Hanisch FG. Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 2009; 9:2820-35; PMID:19415654; http://dx.doi.org/10.1002/pmic.200800793
37. Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem 2012; 428:44-53; ID:22691960;http://dx.doi.org/10.1016/j.ab.2012.06.004
38. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 2009; 100:1603-7; PMID:19401683; http://dx.doi.org/10.1038/sj.bjc.6605058
39. Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007; 6:4646-55; PMID:17956143; http://dx.doi.org/10.1021/pr070192y
40. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 2009; 8:2014-8; PMID:19535896; http://dx.doi.org/10.4161/cc.8.13.8988
41. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2008; 15:80-8; PMID:17932500; http://dx.doi.org/10.1038/sj.cdd.4402237
42. Fidler IJ, Poste G. The "seed and soil" hypothesis revisited. Lancet Oncol 2008; 9:808; PMID:18672217; http://dx.doi.org/10.1016/S1470-2045(08)70201-8
43. Taylor DD, Black PH. Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev Biol (N Y 1985) 1986; 3:33-57.
44. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78:838-48; PMID:20703216; http://dx.doi.org/10.1038/ki.2010.278
45. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inf lammatory response. Proc Natl Acad Sci U S A 2012; 109:E2110-6; PMID:22753494; http://dx.doi.org/10.1073/pnas.1209414109
46. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007; 67:2912-5; PMID:17409393; http://dx.doi.org/10.1158/0008-5472.CAN-07-0520
47. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002; 195:1303-16; PMID:12021310; http://dx.doi.org/10.1084/jem.20011624
48. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284:34211-22; PMID:19801663; http://dx.doi.org/10.1074/jbc.M109.041152
49. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10:619-24; PMID:18425114; http://dx.doi.org/10.1038/ncb1725
50. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 2009; 106:3794-9; PMID:19234131; http://dx.doi.org/10.1073/pnas.0804543106
51. Huber V, Filipazzi P, Iero M, Fais S, Rivoltini L. More insights into the immunosuppressive potential of tumor exosomes. J Transl Med 2008; 6:63; PMID:18973649; http://dx.doi.org/10.1186/1479-5876-6-63
52. Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, Zeidler R, Lang S, Whiteside TL. Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck 2009; 31:371-80; PMID:19073006; http://dx.doi.org/10.1002/hed.20968
53. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-etastatic phenotype through MET. Nat Med 2012; 18:883-91; PMID:22635005; http://dx.doi.org/10.1038/nm.2753
54. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23:377-89; PMID:10199467; http://dx.doi.org/10.1097/00000478-199904000-00002
55. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152:1259-69; PMID:9588894
56. Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY; ESMO Guidelines Working Group. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol 2008; 19:ii35-8; PMID:18456761
57. Rink L, Godwin AK. Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population. Curr Oncol Rep 2009; 11:314-21; PMID:19508837; http://dx.doi.org/10.1007/s11912-009-0044-0
58. DeMatteo RP. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 2002; 9:831-9; PMID:12417503; http://dx.doi.org/10.1007/BF02557518
59. Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, et al. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Mol Cancer Ther 2009; 8:2172-82; PMID:19671739; http://dx.doi.org/10.1158/1535-7163.MCT-09-0193
60. Frolov A, Chahwan S, Ochs M, Arnoletti JP, Pan ZZ, Favorova O, Fletcher J, von Mehren M, Eisenberg B, Godwin AK. Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Mol Cancer Ther 2003; 2:699-709; PMID:12939459
61. Tarn C, Skorobogatko YV, Taguchi T, Eisenberg B, von Mehren M, Godwin AK. Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms. Cancer Res 2006; 66:5477-86; PMID:16707477; http://dx.doi.org/10.1158/0008-5472.CAN-05-3906
62. Belinsky MG, Rink L, Cai KQ, Ochs MF, Eisenberg B, Huang M, von Mehren M, Godwin AK. The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell Cycle 2008; 7:2949-55; PMID:18818517; http://dx.doi.org/10.4161/cc.7.19.6760
63. Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A 2008; 105:8387-92; PMID:18550829; http://dx.doi.org/10.1073/pnas.0803383105
64. Ochs MF, Rink L, Tarn C, Mburu S, Taguchi T, Eisenberg B, Godwin AK. Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data. Cancer Res 2009; 69:9125-32; PMID:19903850; http://dx.doi.org/10.1158/0008-5472.CAN-09-1709
65. Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors. Clin Colorectal Cancer 2006; 6:S7-17; PMID:17101067; http://dx.doi.org/10.3816/CCC.2006.s.002
66. Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, et al. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer 2009; 48:886-96; PMID:19585585; http://dx.doi.org/10.1002/gcc.20689
67. Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 1999; 17:131-40; PMID:10411105; http://dx.doi.org/10.1023/A:1006500406240
68. Dolo V, Ginestra A, Cassará D, Ghersi G, Nagase H, Vittorelli ML. Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes. Ann N Y Acad Sci 1999; 878:497-9; PMID:10415753; http://dx.doi.org/10.1111/j.1749-6632.1999.tb07707.x e28231-6 Communicative & Integrative Biology V olume 7 Issue I
69. Sezonlin M, Dupas S, Le Rü B, Le Gall P, Moyal P, Calatayud PA, Giffard I, Faure N, Silvain JF. Phylogeography and population genetics of the maize stalk borer Busseola fusca (Lepidoptera, Noctuidae) in sub-Saharan Africa. Mol Ecol 2006; 15:407-20; PMID:16448409; http://dx.doi.org/10.1111/j.1365-294X.2005.02761.x
70. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64:7045-9; PMID:15466198; http://dx.doi.org/10.1158/0008-5472.CAN-04-1800
71. McCready J, Sims JD, Chan D, Jay DG. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 2010; 10:294; PMID:20553606; http://dx.doi.org/10.1186/1471-2407-10-294
72. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23:912-23; PMID:11598958; http://dx.doi.org/10.1002/bies.1132
73. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-esenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42; PMID:16493418; http://dx.doi.org/10.1038/nrm1835
74. Lin F, Cao J, Gu WL, Fan SF, Li KP, Du H, Chen GQ, Wen MJ, Dai LH, Lai YY. Clinical experience in diagnosis and treatment of malignant gastrointestinal stromal tumors. Kaohsiung J Med Sci 2012; 28:212-5; PMID:22453069; http://dx.doi.org/10.1016/j.kjms.2011.10.014
75. von Mehren M, Watson JC. Gastrointestinal stromal tumors. [vii.]. Hematol Oncol Clin North Am 2005; 19:547-64, vii; PMID:15939196; http://dx.doi.org/10.1016/j.hoc.2005.03.010
76. Bendardaf R, Lamlum H, Vihinen P, Ristamäki R, Laine J, Pyrhönen S. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology 2003; 65:337-46; PMID:14707454; http://dx.doi.org/10.1159/000074647
77. Yamashita K, Mori M, Kataoka A, Inoue H, Sugimachi K. The clinical significance of MMP-1 expression in oesophageal carcinoma. Br J Cancer 2001; 84:276-82; PMID:11161388; http://dx.doi.org/10.1054/bjoc.2000.1568
78. Sawatsubashi M, Mizokami H, Tokunaga O, Shin T. Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma. Mod Pathol 1998; 11:878-85; PMID:9758368
79. Dudeja V, Armstrong LH, Gupta P, Ansel H, Askari S, Al-Refaie WB. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection. J Gastrointest Surg 2010; 14:557-61; PMID:20033343; http://dx.doi.org/10.1007/s11605-009-1121-2
80. Yuan J, Dutton CM, Scully SP. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 2005; 23:1467-74; PMID:15927440; http://dx.doi.org/10.1016/j.orthres.2005.04.004.1100230633
81. Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci U S A 2014; 111:711-6; PMID:24379393; http://dx.doi.org/10.1073/pnas.1310501111
82. Noël A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008; 19:52-60; PMID:17625931; http://dx.doi. org/10.1016/j.semcdb.2007.05.011
83. Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009; 25:30-8; PMID:19054589; http://dx.doi.org/10.1016/j.tig.2008.10.012
84. Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 2009; 8:1409-20; PMID:19509247; http://dx.doi.org/10.1158/1535-7163.MCT-08-0860
85. Viswanathan M, Sangiliyandi G, Vinod SS, Mohanprasad BK, Shanmugam G. Genomic instability and tumor-specific alterations in oral squamous cell carcinomas assessed by inter-(simple sequence repeat) PCR. Clin Cancer Res 2003; 9:1057-62; PMID:12631607
86. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr., Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.org/10.1038/ncb1800
87. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ, Zembala M. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006; 55:808-18; PMID:16283305; http://dx.doi.org/10.1007/s00262-005-0075-9
88. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151:1542-56; PMID:23260141; http://dx.doi.org/10.1016/j.cell.2012.11.024
89. Cho JA, Park H, Lim EH, Kim KH, Choi JS, Lee JH, Shin JW, Lee KW. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol Oncol 2011; 123:379-86; PMID:21903249; http://dx.doi.org/10.1016/j.ygyno.2011.08.005
90. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 2011; 71:1550-60; PMID:21343399; http://dx.doi.org/10.1158/0008-5472.CAN-10-2372
91. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 2010; 70:9621-30; PMID:21098712; http://dx.doi.org/10.1158/0008-5472.CAN-10-1722